nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques
|
Schadeck, Eva B. |
|
2006 |
24 |
21 |
p. 4677-4687 11 p. |
artikel |
2 |
A multivalent HIV-vaccine: development of a plasmid DNA for the expression of HIV envelope glycoproteins with hypervariable V3-loop domains
|
Schilling, R. |
|
2006 |
24 |
21 |
p. 4648-4650 3 p. |
artikel |
3 |
A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations
|
Hinkula, Jorma |
|
2006 |
24 |
21 |
p. 4494-4497 4 p. |
artikel |
4 |
A novel electroporation device for gene delivery in large animals and humans
|
Tjelle, Torunn Elisabeth |
|
2006 |
24 |
21 |
p. 4667-4670 4 p. |
artikel |
5 |
Assessment of epidermal cell viability by near infrared multi-photon microscopy following ballistic delivery of gold micro-particles
|
Raju, Paul A. |
|
2006 |
24 |
21 |
p. 4644-4647 4 p. |
artikel |
6 |
Baboon as a nonhuman primate model for vaccine studies
|
Murthy, Krishna K. |
|
2006 |
24 |
21 |
p. 4622-4624 3 p. |
artikel |
7 |
Comparison of the immunological memory after DNA vaccination and protein vaccination against anthrax in sheep
|
Hahn, Ulrike K. |
|
2006 |
24 |
21 |
p. 4595-4597 3 p. |
artikel |
8 |
CpG motifs as adjuvant in DNA vaccination against Chlamydophila psittaci in turkeys
|
Loots, Karolien |
|
2006 |
24 |
21 |
p. 4598-4601 4 p. |
artikel |
9 |
Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center
|
Bergman, P.J. |
|
2006 |
24 |
21 |
p. 4582-4585 4 p. |
artikel |
10 |
DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates
|
Li, Zhongming |
|
2006 |
24 |
21 |
p. 4565-4568 4 p. |
artikel |
11 |
DNA vaccination against anthrax in mice—combination of anti-spore and anti-toxin components
|
Hahn, Ulrike K. |
|
2006 |
24 |
21 |
p. 4569-4571 3 p. |
artikel |
12 |
DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus
|
Costa, S.M. |
|
2006 |
24 |
21 |
p. 4562-4564 3 p. |
artikel |
13 |
Editorial Board
|
|
|
2006 |
24 |
21 |
p. CO2- 1 p. |
artikel |
14 |
Effect of different nuclear localization sequences on the immune responses induced by a MIDGE vector encoding bovine herpesvirus-1 glycoprotein D
|
Zheng, Chunfu |
|
2006 |
24 |
21 |
p. 4625-4629 5 p. |
artikel |
15 |
Efficacy evaluation of Der p 1 DNA vaccine for allergic asthma in an experimental mouse model
|
HuangFu, TaoQi |
|
2006 |
24 |
21 |
p. 4576-4581 6 p. |
artikel |
16 |
Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy
|
Otero, Miguel |
|
2006 |
24 |
21 |
p. 4461-4470 10 p. |
artikel |
17 |
Engineering of needle-free physical methods to target epidermal cells for DNA vaccination
|
Kendall, Mark |
|
2006 |
24 |
21 |
p. 4651-4656 6 p. |
artikel |
18 |
Enhancement of immune responses to an HBV DNA vaccine by electroporation
|
Luxembourg, A. |
|
2006 |
24 |
21 |
p. 4490-4493 4 p. |
artikel |
19 |
Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O
|
Li, Yanmin |
|
2006 |
24 |
21 |
p. 4602-4606 5 p. |
artikel |
20 |
Epidermal DNA vaccine for influenza is immunogenic in humans
|
Drape, Robert J. |
|
2006 |
24 |
21 |
p. 4475-4481 7 p. |
artikel |
21 |
Evaluation of the immunogenicity of pBudCE4.1 plasmids encoding mycolyl-transferase Ag85A and phosphate transport receptor PstS-3 from Mycobacterium tuberculosis
|
Romano, Marta |
|
2006 |
24 |
21 |
p. 4640-4643 4 p. |
artikel |
22 |
Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: Transgene expression, immunity and safety
|
Rinaldi, Monica |
|
2006 |
24 |
21 |
p. 4586-4591 6 p. |
artikel |
23 |
Genetic stability of recombinant MVA-BN
|
Timm, Alexandra |
|
2006 |
24 |
21 |
p. 4618-4621 4 p. |
artikel |
24 |
Genetic vaccination for production of DNA-designed antibodies specific to Hepadnavirus envelope proteins
|
Abouzid, Karima |
|
2006 |
24 |
21 |
p. 4615-4617 3 p. |
artikel |
25 |
HIV-1 reverse transcriptase targeted for proteasomal degradation as a prototype vaccine against drug-resistant HIV-1
|
Starodubova, Elizaveta |
|
2006 |
24 |
21 |
p. 4541-4547 7 p. |
artikel |
26 |
Immunization with a gene encoding granulocyte-macrophage colony-stimulating factor inserted with a single helper T-cell epitope of an intracellular bacterium induces a specific T-cell subset and protective immunity
|
Nagata, Toshi |
|
2006 |
24 |
21 |
p. 4548-4553 6 p. |
artikel |
27 |
Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers
|
Mancini - Bourgine, Maryline |
|
2006 |
24 |
21 |
p. 4482-4489 8 p. |
artikel |
28 |
Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus
|
Spik, Kristin |
|
2006 |
24 |
21 |
p. 4657-4666 10 p. |
artikel |
29 |
Immunological cross-reactivity against a drug mutated HIV-1 protease epitope after DNA multi-CTL epitope construct immunization
|
Boberg, Andreas |
|
2006 |
24 |
21 |
p. 4527-4530 4 p. |
artikel |
30 |
Introduction to DNA Vaccines Issue
|
Weiner, David B. |
|
2006 |
24 |
21 |
p. 4459-4460 2 p. |
artikel |
31 |
Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice
|
Kutzler, Michele A. |
|
2006 |
24 |
21 |
p. 4630-4639 10 p. |
artikel |
32 |
pDNAVACCultra vector family: high throughput intracellular targeting DNA vaccine plasmids
|
Williams, James A |
|
2006 |
24 |
21 |
p. 4671-4676 6 p. |
artikel |
33 |
Plasmid-encoded GM-CSF induces priming of the F4(K88)-specific serum IgA response by FaeG DNA vaccination in pigs
|
Melkebeek, V. |
|
2006 |
24 |
21 |
p. 4592-4594 3 p. |
artikel |
34 |
Potent immunogenicity of an HIV-1 gag–pol fusion DNA vaccine delivered by in vivo electroporation
|
Otten, Gillis R. |
|
2006 |
24 |
21 |
p. 4503-4509 7 p. |
artikel |
35 |
Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice
|
Egan, Michael A. |
|
2006 |
24 |
21 |
p. 4510-4523 14 p. |
artikel |
36 |
Reduced cellular immune responses following immunization with a multi-gene HIV-1 vaccine
|
Bråve, Andreas |
|
2006 |
24 |
21 |
p. 4524-4526 3 p. |
artikel |
37 |
Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine
|
Wang, Shixia |
|
2006 |
24 |
21 |
p. 4531-4540 10 p. |
artikel |
38 |
Responses of mice immunized with a DNA vaccine encoding carcinoembryonic antigen (CEA)
|
Johansson, Susanne |
|
2006 |
24 |
21 |
p. 4572-4575 4 p. |
artikel |
39 |
Rhesus macaques with high levels of vaccine induced IFN-gamma producing cells better control viral set-point following challenge with SIV239
|
Boyer, Jean D. |
|
2006 |
24 |
21 |
p. 4498-4502 5 p. |
artikel |
40 |
Successful parallel development and integration of a plasmid-based biologic, container/closure system and electrokinetic delivery device
|
Hebel, Henry |
|
2006 |
24 |
21 |
p. 4607-4614 8 p. |
artikel |
41 |
Synergistic DNA–MVA prime-boost vaccination regimes for malaria and tuberculosis
|
Gilbert, Sarah C. |
|
2006 |
24 |
21 |
p. 4554-4561 8 p. |
artikel |
42 |
The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun
|
Williman, Jonathan |
|
2006 |
24 |
21 |
p. 4471-4474 4 p. |
artikel |